The report "Live-cell imaging" Market by Product (Equipment, Software, and Consumables), Application (Cell Biology, Stem Cell & Drug Discovery, and developmental Biology), Technology (High content screening, Fluorescence recovery after photobleaching, Time-lapse microscopy, Fluorescence resonance energy transfer, and others), & Region (North America, Europe, Asia Pacific, and Rest of the world)- Global Forecast to 2030. "The Global live-cell imaging Market share was USD 1.8 Bn in 2020. The market is assumed to reach USD 4.18 Bn by 2030, representing a CAGR of 8.8 % throughout the forecasted period.
To know more about the report, Click on the link :- https://www.strategicmarketresearch.com/market-report/live-cell-imaging-market
KEY FACTORS THAT ARE CONTINUOUSLY AUGMENTING THE MARKET GROWTH
Some of the most notable factors that are driving the market's overall growth worldwide are the rise in the adoption of high content screening in drug discovery and the rising issue of chronic diseases.
By Product, the 'Equipment 'segment held the highest share in 2020
Based on the Product, the Live cell imaging market has been segmented into Equipment, Software and Consumables. Here, the Equipment segment comprehensively held the largest market share. The standalone system from the equipment segment is expected to hold a significant percentage. These systems can function without any other hardware. The major driving factors that can be attributed to the growth of this segment are the effective use of these systems in live-cell imaging and the increased focus on R&D.
By Application, the 'Cell Biology' segment held the most significant share of the market in 2020
On the basis of the Applications, the Live cell imaging market has been fragmented into Cell Biology, Stem Cell & Drug Discovery, and Developmental Biology. Cell Biology has the largest market share in this segment due to the rising number of research activities on molecular interaction networks. Apart from this, advanced illumination systems and filter techniques are innovations that drive the process.
By Technology, the 'Fluorescence resonance energy transfer' segment held the largest share of the market in 2020
On the basis of Technology, the Live cell imaging market has been divided into High content screening (HCS), Fluorescence recovery after photobleaching (FRAP), Time-lapse microscopy, and fluorescence resonance energy transfer (FRET). In this segment, the Fluorescence resonance energy transfer segment holds the largest share because of its advantage in ascertaining the spatial proximity in the protein levels. Furthermore, this technology became popular in recent times due to the increase in the Application of genetic peptides.
By Region, the "Asia Pacific" accounted for the maximum share of the market in 2020
Based on Regions, the Live cell imaging market is clustered in North America, Europe, Asia Pacific, and the Rest of the World. The Asia Pacific has the highest rate because of the government initiatives for stem cell therapy research, the growth of clinical research in China, and the rising demand for regenerative medicinal research.
SOME OF THE NOTABLE PLAYERS ARE PREVAILING IN THE MARKET.
Some of the leading players in the Live-cell imaging Market include Danaher Corporation, Carl Zeiss AG, Nikon Corporation, Olympus Corporation, PerkinElmer, Inc., G.E. Healthcare, Bruker Corporation, Thermo Fisher Scientific Inc., Sartorius AG, Oxford Instruments, BioTek Instruments, Etaluma Inc., CytoSMART Technologies, NanoEnTek Inc., Phase Focus Limited, Tomocube Inc., Phase Holographic Imaging PHI AB, B.D. Biosciences, Sony Biotechnology Inc., Merck KGaA, KEYENCE Corporation, ibidi GmbH, Bio-Rad Laboratories, Logos Biosystems, and Nanolive SA.
Recent Developments: -